M
CEL

MetLife’s Cellcom Israel, Ltd. CEL Stock Holding History

MetLife’s Portfolio CEL Stock Details CEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-196,385
Closed -$13.1M – 7
2020
Q4 		$13.1M Hold
196,385
– – 53.36% 1
2020
Q3 		$11.9M Hold
196,385
– – 54.67% 1
2020
Q2 		$11.4M Hold
196,385
– – 53.9% 1
2020
Q1 		$11.3M Hold
196,385
– – 57.26% 1
2019
Q4 		$12.8M Hold
196,385
– – 50.95% 1
2019
Q3 		$13.2M Hold
196,385
– – 51.83% 1
2019
Q2 		$13.8M Hold
196,385
– – 58.67% 1
2019
Q1 		$13.6M Buy
+196,385
New +$947K 44.89% 1

Other funds holding CEL

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CFG
CKW Financial Group Honolulu, Hawaii $917M AUM 18.41% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

MetLife's CEL Position: Q1 2021 in Review

MetLife sold out of Cellcom Israel, Ltd. (CEL) in Q1 2021, closing a stake of 196,385 shares — an estimated $13.1M sold.

MetLife first reported a position in CEL in Q1 2019 and held it in 8 quarters. The position peaked at $13.8M in Q2 2019. 12 funds tracked by Wall St. Rank hold CEL as of Q1 2021.

  • MetLife reported no remaining Cellcom Israel, Ltd. position as of Q1 2021 after selling out during the quarter.
  • MetLife sold 196,385 Cellcom Israel, Ltd. shares in Q1 2021, an estimated $13.1M.
  • MetLife first reported a position in Cellcom Israel, Ltd. in Q1 2019 and held it in 8 quarters.
  • MetLife's Cellcom Israel, Ltd. position peaked at $13.8M in Q2 2019.
  • 12 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q1 2021.

Based on MetLife's 13F filing for Q1 2021, filed 23 Mar 2023.